SLDB
Solid Biosciences LLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$651.74M
P/E Ratio
—
EPS
$-1.92
Beta
2.47
52W High
$8.87
52W Low
$2.83
50-Day MA
$7.45
200-Day MA
$6.17
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Solid Biosciences LLC
Solid Biosciences Inc., a life sciences company, is dedicated to developing therapies for Duchenne muscular dystrophy (DMD) in the United States. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-96.43M |
| EBITDA | $-194.84M |
| Operating Margin | 0.00% |
| Return on Equity | -57.40% |
| Return on Assets | -32.00% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $3.80 |
| Price-to-Book | 1.75 |
| Price-to-Sales (TTM) | 3.65 |
| EV/Revenue | 1.156 |
| EV/EBITDA | -3.69 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -100.00% |
| Shares Outstanding | $98.45M |
| Float | $53.74M |
| % Insiders | 0.82% |
| % Institutions | 101.69% |
Historical Volatility
HV 10-Day
87.68%
HV 20-Day
72.17%
HV 30-Day
64.30%
HV 60-Day
88.75%
HV Rank
13.5%
Volatility is currently expanding
Analyst Ratings
Consensus ($17.00 target)
4
Strong Buy10
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026